The FY19 Defense Appropriation provides $20 million (M) to the Department of Defense Kidney Cancer Research Program (KCRP)to support research of exceptional scientific merit in the area of kidney cancer. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).
FY19 KCRP Program Announcements and General Application Instructions for the following award mechanisms are e posted on the Grants.gov website.
https://cdmrp.army.mil/funding/kcrp
Concept Award – Letter of Intent due September 17, 2019
All investigators at or above the level of postdoctoral fellow (or equivalent) are eligible.
- Supports highly innovative, untested, potentially groundbreaking concepts in kidney cancer
- Emphasis on innovation
- Clinical trials not allowed
- Preliminary data not allowed
- Blinded review
- Maximum funding of $75,000 for direct costs (plus indirect costs)
- Maximum period of performance 1 year
- Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement
Idea Development Award – Letter of Intent due September 17, 2019
Established Investigators:
Independent investigators at or above the level of Assistant Professor (or equivalent) and 10 years or more from a terminal degree; or
Early Career Investigators:
Investigators at the level of Assistant Professor, Instructor, or Assistant Research Professor (or equivalent) and less than 10 years from a terminal degree (excluding time spent in medical residency or family medical leave) at the time of application submission deadline are eligible
· Supports new ideas that represent innovative, high-risk/high-gain approaches to kidney cancer research, and have the potential to make an important contribution to kidney cancer
· Preliminary data required
· Innovation and Impact are the most important review criteria
· Clinical trials not allowed
- FY19 KCRP Areas of Emphasis strongly encouraged
- Maximum funding of $400,000 in direct costs (plus indirect costs)
- Maximum period of performance 2 years
- Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement
Translational Research Partnership Award – Letter of Intent due September 17, 2019
The Initiating PI must be at or above the level of Assistant Professor or equivalent.
The Partnering PI must be at or above the level of Assistant Professor or equivalent.
Postdoctoral fellows are not eligible to be Partnering PIs.
· Supports partnerships between clinicians and laboratory scientists that accelerate ideas in kidney cancer into clinical applications
· Supports translational correlative studies
· Preliminary data required
· Clinical trials not allowed
· Maximum funding of $600,000 for direct costs (plus indirect costs)
· Maximum period of performance 3 years
· Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the KCRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Help Desk
301-682-5507
help@eBrap.org
Promoting Partnerships To Improve Veterans’ Health